Induction of G2/M Phase Arrest and Apoptosis by Oridonin in Human Laryngeal Carcinoma Cells
Oridonin (1), an active component isolated from the plant Rabdosia rubescens, has been reported to exhibit antitumor effects. In this study, the mechanism involved in 1-induced growth inhibition, including apoptosis and G2/M phase arrest, in human laryngeal carcinoma HEp-2 cells deficient in functio...
Saved in:
Published in | Journal of natural products (Washington, D.C.) Vol. 73; no. 6; pp. 1058 - 1063 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Northbrook, IL
American Chemical Society and American Society of Pharmacognosy
25.06.2010
American Society of Pharmacognosy |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Oridonin (1), an active component isolated from the plant Rabdosia rubescens, has been reported to exhibit antitumor effects. In this study, the mechanism involved in 1-induced growth inhibition, including apoptosis and G2/M phase arrest, in human laryngeal carcinoma HEp-2 cells deficient in functional p53, was investigated for the first time. Compound 1 triggered the mitochondrial apoptotic pathway, as indicated by increased Bax/Bcl-2 ratios, reduction of mitochondrial membrane potential (ΔΨm), and substantial increase in apoptosis-inducing factor (AIF) and cytochrome c. Inhibition of caspase-9 in HEp-2 cells did not protect the cells from 1-induced apoptosis, and cleaved caspase-9 was not detected, indicating that apoptosis occurred via a caspase-9-independent pathway. The results also suggested that G2/M phase arrest and apoptosis mediated by 1 occurred via a p53-independent but in a p21/WAF1-dependent manner in HEp-2 cells. In addition, the generation of reactive oxygen species (ROS) was found to be a critical mediator in growth inhibition induced by 1. Taken together, the results indicate that oridonin (1) is a potentially effective agent for the treatment of laryngeal squamous cell carcinoma. |
---|---|
ISSN: | 0163-3864 1520-6025 |
DOI: | 10.1021/np9008199 |